S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
All the trading advice you’ve ever received boils down to this (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
All the trading advice you’ve ever received boils down to this (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Broadcom falls into a buy-the-dip opportunity 
All the trading advice you’ve ever received boils down to this (Ad)
Closing prices for crude oil, gold and other commodities
A 'soft landing' or a recession? How each one might affect America's households and businesses
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
All the trading advice you’ve ever received boils down to this (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
All the trading advice you’ve ever received boils down to this (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Broadcom falls into a buy-the-dip opportunity 
All the trading advice you’ve ever received boils down to this (Ad)
Closing prices for crude oil, gold and other commodities
A 'soft landing' or a recession? How each one might affect America's households and businesses
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
All the trading advice you’ve ever received boils down to this (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
All the trading advice you’ve ever received boils down to this (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Broadcom falls into a buy-the-dip opportunity 
All the trading advice you’ve ever received boils down to this (Ad)
Closing prices for crude oil, gold and other commodities
A 'soft landing' or a recession? How each one might affect America's households and businesses
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
All the trading advice you’ve ever received boils down to this (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
All the trading advice you’ve ever received boils down to this (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Broadcom falls into a buy-the-dip opportunity 
All the trading advice you’ve ever received boils down to this (Ad)
Closing prices for crude oil, gold and other commodities
A 'soft landing' or a recession? How each one might affect America's households and businesses

Rigel Pharmaceuticals (RIGL) Earnings Date, Estimates & Call Transcripts

$1.32
+0.19 (+16.74%)
(As of 12/8/2023 ET)
Compare
Today's Range
$1.14
▼
$1.34
50-Day Range
$0.72
▼
$1.14
52-Week Range
$0.71
▼
$2.04
Volume
1.75 million shs
Average Volume
1.30 million shs
Market Capitalization
$231.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.67
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Mar. 5Estimated
Actual EPS
(Nov. 7)
-$0.03 Beat By $0.04
Consensus EPS
(Nov. 7)
-$0.07
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

RIGL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RIGL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Rigel Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20234($0.11)($0.07)($0.10) 
Q2 20234($0.11)($0.08)($0.09) 
Q3 20234($0.10)($0.06)($0.08) 
Q4 20234($0.10)($0.04)($0.07) 
FY 202316($0.42)($0.25)($0.33) 
Q1 20241($0.06)($0.06)($0.06) 
Q2 20241($0.04)($0.04)($0.04) 
Q3 20241($0.04)($0.04)($0.04) 
Q4 20241($0.02)($0.02)($0.02) 
FY 20244($0.16)($0.16) ($0.16)

RIGL Earnings Date and Information

Rigel Pharmaceuticals last posted its earnings results on November 7th, 2023. The biotechnology company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.07) by $0.04. The company earned $28.13 million during the quarter, compared to analysts' expectations of $27.83 million. Rigel Pharmaceuticals has generated ($0.14) earnings per share over the last year (($0.14) diluted earnings per share). Earnings for Rigel Pharmaceuticals are expected to grow in the coming year, from ($0.19) to ($0.08) per share. Rigel Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 5th, 2024 based off prior year's report dates.

Rigel Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/5/2024
Estimated)		------- 
11/7/2023Q3 2023($0.07)($0.03)+$0.04($0.03)$27.83 million$28.13 million    
8/1/2023Q2 2023($0.08)($0.04)+$0.04($0.04)$26.02 million$26.89 million    
5/2/2023Q1 2023($0.09)($0.08)+$0.01($0.08)$24.29 million$26.07 million
3/7/2023Q4 2022($0.07)$0.01+$0.08$0.01$37.55 million$51.28 million    
11/3/2022Q3 2022($0.13)($0.11)+$0.02($0.11)$22.76 million$22.41 million
8/2/2022Q2 2022($0.12)($0.08)+$0.04($0.08)$23.56 million$29.82 million
5/3/2022Q1 2022($0.12)($0.16)($0.04)($0.16)$18.49 million$16.74 million    
3/1/2022Q4 2021($0.13)($0.13)-($0.13)$21.20 million$20.41 million    
11/2/2021Q3 2021($0.10)($0.12)($0.02)($0.12)$24.16 million$21.54 million    
8/3/2021Q2 2021($0.11)($0.08)+$0.03($0.08)$22.08 million$26.27 million    
5/5/2021Q1 2021$0.01$0.22+$0.21$0.22$40.06 million$81.02 million  
3/1/2021Q4 2020($0.11)($0.11)-($0.11)$18.37 million$18.45 million  












Rigel Pharmaceuticals Earnings - Frequently Asked Questions

When is Rigel Pharmaceuticals's earnings date?

Rigel Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 5th, 2024 based off last year's report dates. Learn more on RIGL's earnings history.

Did Rigel Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Rigel Pharmaceuticals (NASDAQ:RIGL) reported ($0.03) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.07) by $0.04. Learn more on analysts' earnings estimate vs. RIGL's actual earnings.

How can I listen to Rigel Pharmaceuticals's earnings conference call?

The conference call for Rigel Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call

How can I read Rigel Pharmaceuticals's conference call transcript?

The conference call transcript for Rigel Pharmaceuticals's latest earnings report can be read online. Read Transcript

How much revenue does Rigel Pharmaceuticals generate each year?

Rigel Pharmaceuticals (NASDAQ:RIGL) has a recorded annual revenue of $132.37 million.

How much profit does Rigel Pharmaceuticals generate each year?

Rigel Pharmaceuticals (NASDAQ:RIGL) has a recorded net income of -$58.57 million. RIGL has generated -$0.14 earnings per share over the last four quarters.

What is Rigel Pharmaceuticals's EPS forecast for next year?

Rigel Pharmaceuticals's earnings are expected to grow from ($0.19) per share to ($0.08) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:RIGL) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -